Skip to main content
Fig. 5 | Acta Neuropathologica Communications

Fig. 5

From: Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma

Fig. 5

Retinal ganglion cell dendrite changes following induction of unilateral ocular hypertension with interventional low dose NAM treatment compared to untreated unilateral glaucoma. The IOP profiles and Sholl analysis follow the conventions for Fig. 2. The red lines on the IOP plot (A) indicate the start of NAM treatment 3 days after the induction of elevated IOP

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us